只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-27 2026-07-29 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham Director,Officer · Chief Executive Officer | 卖出（S） | 2,203 | US$42.11 | US$92,761.72 | 537,614 | SEC |
| 2026-07-27 2026-07-29 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham Director,Officer · Chief Executive Officer | 卖出（S） | 7 | US$42.74 | US$299.15 | 537,607 | SEC |
| 2026-07-21 2026-07-23 | AWF ALLIANCEBERNSTEIN GLOBAL HIGH INCOME FUND INC | Wrapp Emilie D. Director | 买入（P） | 3,432 | US$10.19 | US$34,971.39 | 5,824.504 | SEC |
| 2026-07-14 2026-07-15 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham Director,Officer · Chief Executive Officer | 卖出（S） | 5,481 | US$39.72 | US$217,714.64 | 542,546 | SEC |
| 2026-07-14 2026-07-15 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham Director,Officer · Chief Executive Officer | 卖出（S） | 2,729 | US$40.57 | US$110,722.08 | 539,817 | SEC |
| 2026-06-30 2026-07-01 | RAPP Rapport Therapeutics, Inc. | Gault Cheryl Officer · Chief Operating Officer | 卖出（S） | 1,900 | US$40.09 | US$76,173.66 | 158,014 | SEC |
| 2026-06-30 2026-07-01 | RAPP Rapport Therapeutics, Inc. | Gault Cheryl Officer · Chief Operating Officer | 卖出（S） | 3,792 | US$41.39 | US$156,963.77 | 154,222 | SEC |
| 2026-06-30 2026-07-01 | RAPP Rapport Therapeutics, Inc. | Gault Cheryl Officer · Chief Operating Officer | 卖出（S） | 3,308 | US$42.17 | US$139,505.64 | 150,914 | SEC |
| 2026-06-30 2026-07-01 | RAPP Rapport Therapeutics, Inc. | Gault Cheryl Officer · Chief Operating Officer | 卖出（S） | 1,000 | US$43.15 | US$43,154.70 | 149,914 | SEC |
| 2026-06-29 2026-07-01 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham Director,Officer · Chief Executive Officer | 卖出（S） | 7,344 | US$39.77 | US$292,062.07 | 548,903 | SEC |
| 2026-06-29 2026-07-01 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham Director,Officer · Chief Executive Officer | 卖出（S） | 876 | US$40.34 | US$35,335.65 | 548,027 | SEC |
| 2026-06-01 2026-06-03 | PLXS PLEXUS CORP | Rapp Karen Marie Director | 卖出（S） | 500 | US$270.00 | US$135,000.00 | 8,035 | SEC |
| 2026-05-26 2026-05-28 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures V, L.P. TenPercentOwner | 卖出（S） | 18,572 | US$40.05 | US$743,808.60 | 6,280,525 | SEC |
| 2026-05-26 2026-05-28 | RAPP Rapport Therapeutics, Inc. | TRV GP VI, LLC TenPercentOwner | 卖出（S） | 18,572 | US$40.05 | US$743,808.60 | 6,280,525 | SEC |
| 2026-05-26 2026-05-28 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures VI, L.P. TenPercentOwner | 卖出（S） | 18,572 | US$40.05 | US$743,808.60 | 6,280,525 | SEC |
| 2026-05-26 2026-05-28 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures GP VI, L.P. TenPercentOwner | 卖出（S） | 18,572 | US$40.05 | US$743,808.60 | 6,280,525 | SEC |
| 2026-05-26 2026-05-28 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures GP V, LP TenPercentOwner | 卖出（S） | 18,572 | US$40.05 | US$743,808.60 | 6,280,525 | SEC |
| 2026-05-26 2026-05-28 | RAPP Rapport Therapeutics, Inc. | TRV GP V, LLC TenPercentOwner | 卖出（S） | 18,572 | US$40.05 | US$743,808.60 | 6,280,525 | SEC |
| 2026-05-11 2026-05-13 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures V, L.P. TenPercentOwner | 卖出（S） | 133,618 | US$40.24 | US$537.68万 | 6,299,097 | SEC |
| 2026-05-11 2026-05-13 | RAPP Rapport Therapeutics, Inc. | TRV GP VI, LLC TenPercentOwner | 卖出（S） | 133,618 | US$40.24 | US$537.68万 | 6,299,097 | SEC |
| 2026-05-11 2026-05-13 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures VI, L.P. TenPercentOwner | 卖出（S） | 133,618 | US$40.24 | US$537.68万 | 6,299,097 | SEC |
| 2026-05-11 2026-05-13 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures GP VI, L.P. TenPercentOwner | 卖出（S） | 133,618 | US$40.24 | US$537.68万 | 6,299,097 | SEC |
| 2026-05-11 2026-05-13 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures GP V, LP TenPercentOwner | 卖出（S） | 133,618 | US$40.24 | US$537.68万 | 6,299,097 | SEC |
| 2026-05-11 2026-05-13 | RAPP Rapport Therapeutics, Inc. | TRV GP V, LLC TenPercentOwner | 卖出（S） | 133,618 | US$40.24 | US$537.68万 | 6,299,097 | SEC |
| 2026-05-08 2026-05-11 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures VI, L.P. TenPercentOwner | 卖出（S） | 5,018 | US$40.31 | US$202,275.58 | 6,432,715 | SEC |
| 2026-05-08 2026-05-11 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures V, L.P. TenPercentOwner | 卖出（S） | 5,018 | US$40.31 | US$202,275.58 | 6,432,715 | SEC |
| 2026-05-08 2026-05-11 | RAPP Rapport Therapeutics, Inc. | TRV GP V, LLC TenPercentOwner | 卖出（S） | 5,018 | US$40.31 | US$202,275.58 | 6,432,715 | SEC |
| 2026-05-08 2026-05-11 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures GP VI, L.P. TenPercentOwner | 卖出（S） | 5,018 | US$40.31 | US$202,275.58 | 6,432,715 | SEC |
| 2026-05-08 2026-05-11 | RAPP Rapport Therapeutics, Inc. | TRV GP VI, LLC TenPercentOwner | 卖出（S） | 5,018 | US$40.31 | US$202,275.58 | 6,432,715 | SEC |
| 2026-05-08 2026-05-11 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures GP V, LP TenPercentOwner | 卖出（S） | 5,018 | US$40.31 | US$202,275.58 | 6,432,715 | SEC |
| 2026-05-07 2026-05-11 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures VI, L.P. TenPercentOwner | 卖出（S） | 271,495 | US$40.12 | US$1089.24万 | 6,437,733 | SEC |
| 2026-05-07 2026-05-11 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures V, L.P. TenPercentOwner | 卖出（S） | 271,495 | US$40.12 | US$1089.24万 | 6,437,733 | SEC |
| 2026-05-07 2026-05-11 | RAPP Rapport Therapeutics, Inc. | TRV GP V, LLC TenPercentOwner | 卖出（S） | 271,495 | US$40.12 | US$1089.24万 | 6,437,733 | SEC |
| 2026-05-07 2026-05-11 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures GP VI, L.P. TenPercentOwner | 卖出（S） | 271,495 | US$40.12 | US$1089.24万 | 6,437,733 | SEC |
| 2026-05-07 2026-05-11 | RAPP Rapport Therapeutics, Inc. | TRV GP VI, LLC TenPercentOwner | 卖出（S） | 271,495 | US$40.12 | US$1089.24万 | 6,437,733 | SEC |
| 2026-05-07 2026-05-11 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures GP V, LP TenPercentOwner | 卖出（S） | 271,495 | US$40.12 | US$1089.24万 | 6,437,733 | SEC |
| 2026-04-17 2026-04-21 | RAPP Rapport Therapeutics, Inc. | Yeleswaram Krishnaswamy Officer · Chief Development Officer | 卖出（S） | 20,225 | US$39.99 | US$808,797.75 | 246,426 | SEC |
| 2026-04-17 2026-04-21 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures VI, L.P. TenPercentOwner | 卖出（S） | 426,005 | US$40.32 | US$1717.65万 | 6,709,228 | SEC |
| 2026-04-17 2026-04-21 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures V, L.P. TenPercentOwner | 卖出（S） | 426,005 | US$40.32 | US$1717.65万 | 6,709,228 | SEC |
| 2026-04-17 2026-04-21 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures GP VI, L.P. TenPercentOwner | 卖出（S） | 426,005 | US$40.32 | US$1717.65万 | 6,709,228 | SEC |
| 2026-04-17 2026-04-21 | RAPP Rapport Therapeutics, Inc. | TRV GP VI, LLC TenPercentOwner | 卖出（S） | 426,005 | US$40.32 | US$1717.65万 | 6,709,228 | SEC |
| 2026-04-17 2026-04-21 | RAPP Rapport Therapeutics, Inc. | TRV GP V, LLC TenPercentOwner | 卖出（S） | 426,005 | US$40.32 | US$1717.65万 | 6,709,228 | SEC |
| 2026-04-17 2026-04-21 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures GP V, LP TenPercentOwner | 卖出（S） | 426,005 | US$40.32 | US$1717.65万 | 6,709,228 | SEC |
| 2026-04-16 2026-04-17 | SARO StandardAero, Inc. | Trapp Alex Officer · Chief Strategy Officer | 卖出（S） | 475 | US$27.36 | US$12,996.00 | 1,281 | SEC |
| 2026-04-14 2026-04-14 | RAPP Rapport Therapeutics, Inc. | Yeleswaram Krishnaswamy Officer · Chief Development Officer | 卖出（S） | 10,200 | US$35.08 | US$357,816.00 | 266,651 | SEC |
| 2026-04-13 2026-04-14 | RAPP Rapport Therapeutics, Inc. | Yeleswaram Krishnaswamy Officer · Chief Development Officer | 卖出（S） | 9,165 | US$34.97 | US$320,500.05 | 276,851 | SEC |
| 2026-04-10 2026-04-14 | RAPP Rapport Therapeutics, Inc. | Yeleswaram Krishnaswamy Officer · Chief Development Officer | 卖出（S） | 500 | US$34.98 | US$17,490.00 | 286,016 | SEC |
| 2026-04-08 2026-04-09 | RAPP Rapport Therapeutics, Inc. | Yeleswaram Krishnaswamy Officer · Chief Development Officer | 卖出（S） | 360 | US$34.90 | US$12,564.00 | 286,516 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| RAPP | 54,602.6964 | 0 | 75,688.2295 | 72.14% | B, Q, N |